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Trypanosomatid parasites survive and replicate in the host by using mechanisms
that aim to establish a successful infection and ensure parasite survival. Evidence
points to microRNAs as new players in the host-parasite interplay. MicroRNAs are
small non-coding RNAs that control proteins levels via post-transcriptional gene
down-regulation, either within the cells where they were produced or in other cells via
intercellular transfer. These microRNAs can be modulated in host cells during infection
and are among the growing group of small regulatory RNAs, for which many classes have
been described, including the transfer RNA-derived small RNAs. Parasites can either
manipulate microRNAs to evade host-driven damage and/or transfer small RNAs to host
cells. In this mini-review, we present evidence for the involvement of small RNAs, such
as microRNAs, in trypanosomatid infections which lack RNA interference. We highlight
both microRNA profile alterations in host cells during those infections and the horizontal
transfer of small RNAs and proteins from parasites to the host by membrane-derived
extracellular vesicles in a cell communication mechanism.
Keywords: small RNAs, microRNAs, host-parasite interaction, trypanosomatid infections, extracellular vesicles,
cell communication
INTRODUCTION
Trypanosomatid parasites comprise the African trypanosomes (Trypanosoma brucei), South
american trypanosomes (Trypanosoma cruzi) and Leishmania, that profoundly affect mankind and
substantially impact world public health (Coura and Viñas, 2010; Alvar et al., 2012). The diseases
caused by these parasites predominantly affect the populations of developing regions of Africa, Asia
and the Americas; however, population movement creates a new epidemiological challenge with
worldwide spreading (Coura and Viñas, 2010; Alvar et al., 2012). Through different mechanisms
these parasites establish a successful infection. Among these mechanisms, the small RNAs emerge
as new players in the host-parasite interplay.
Small non-coding RNAs play an essential regulatory role in complex biological systems without
protein translation (Aalto and Pasquinelli, 2012). Of these RNAs, the short-length RNA molecules
(ranging from 20 to 30 nucleotides), such as microRNAs, small interfering RNAs (siRNAs) and
Piwi-interacting RNAs (piRNAs), stand out. Through sequence complementarity, these RNAs
guide recognition of target genes within the ribonucleoprotein (RNP) complex and typically reduce
the expression of a specific gene through the process of RNA interference (RNAi). Despite having
the same mechanism of action, these different classes of regulatory RNAs differ in their association
with Argonaute (AGO) protein family members to form the RNP complex, in their biogenesis,
in their gene regulation pathways and in their biological functions (Ghildiyal and Zamore, 2009).
Furthermore, the world of small non-coding RNAs is expanding, with new classes continuing to
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be discovered, even in organisms that were not previously
thought to express small RNA-mediated pathways, such as
T. cruzi and some Leishmania species (Ullu et al., 2004; Ghildiyal
and Zamore, 2009; Garcia-Silva et al., 2010a,b; Lye et al.,
2010).
RNA-mediated silencing is an evolutionarily conserved
mechanism that may have evolved together with parasite
infection, as parasites developed strategies to interfere with host
microRNA populations, thus recognizing the RNAi pathway
as a new means of reshaping their environment to evade
host immune surveillance and establish a successful infection
(Cerutti and Casas-Mollano, 2006; Hakimi and Cannella,
2011). Obviously, changes in microRNA profiles might also
be a defense mechanism of the infected cell. Nevertheless, the
alteration of host microRNA levels after parasitic infection
has been demonstrated (Geraci et al., 2015; Linhares-Lacerda
et al., 2015), with some data revealing the intricate connection
between the parasite and the RNAi machinery of the host
organism (Ghosh et al., 2013). Moreover, the identification of
predictive microRNA signatures associated with each specific
parasitic infection could aid in the development of tools for
diagnosis, prognosis, monitoring therapy and improving
patient stratifications (Manzano-román and Siles-lucas,
2012).
In this mini-review, we briefly discuss current knowledge
about the involvement of small RNAs in host-parasite
interactions on trypanosomatid parasites that lack the
AGO and Dicer genes and as a consequence do not have
functional RNAi machinery. These parasites include T. cruzi
(the etiologic agent of Chagas disease), Leishmania major and
Leishmania donovani (which cause cutaneous leishmaniasis
and visceral leishmaniasis, respectively). We focus on the
microRNA profile alterations that occur in host cells due
to infection with those parasites and on the trans-kingdom
transfer of small RNAs and proteins from parasites to the host
by membrane-derived extracellular vesicles (EVs) in a cell
communication mechanism that may favor parasite survival.
MicroRNA PROFILE MODULATION DUE
TO PARASITIC INFECTION
The elaborate relationship between parasites and their hosts
aims to establish a successful parasite infection/infestation
and promote survival, with parasites manipulating the host
cellular machinery to avoid and regulate the host immune
effector response (Manzano-román and Siles-lucas, 2012). In
this context, gene expression modulation by microRNAs may
be an ideal tool for parasites because microRNAs can function
as master switches of many biological functions, fine tuning
protein production (Zheng et al., 2013). It is reasonable
to propose that cellular infection will be counteracted by
cellular microRNAs that target crucial host factors as a defense
mechanism; however, parasites subvert microRNA-directed
functions as a means of altering gene expression in host cells
(Hakimi and Cannella, 2011).
MicroRNAs are Related to Cardiac
Alterations and Thymic Atrophy in Chagas
Disease
The alteration of host microRNA levels after T. cruzi infection
has been demonstrated in a murine model (Linhares-Lacerda
et al., 2015; Navarro et al., 2015) and in Chagas disease patients
(Ferreira et al., 2014). Chagas disease is a neglected tropical illness
that is endemic to Latin America (Coura and Borges-pereira,
2012) and has an acute phase characterized by bloodstream
circulating parasites and tissue parasitism, in addition to an
intense immune response and hormonal imbalance (Pérez et al.,
2011). Immune effector responses control T. cruzi numbers in
the blood, and individuals enter the chronic phase of the disease
with low parasites levels in several tissues (de Meis et al., 2013).
Moreover, chronic infection can persist undetected, but∼30% of
patients develop severe complications, such as abnormal heart
rhythm, heart failure, and digestive problems (Clayton, 2010;
World Health Organization, 2010a).
The hearts of mice with experimental acute T. cruzi
infection present an intense inflammatory cell infiltrate with
myocarditis, arrhythmia and parasite nests in addition to
a modified microRNA expression profile. Upon infection,
113 of 641 microRNAs were dysregulated; moreover, some
microRNAs correlated with the maximal heart rate-corrected
QT interval, which is a cardiac alteration (Navarro et al.,
2015). Resembling the experimental model, chronic Chagas
disease patients who develop cardiomyopathy can also present
alterations in heart microRNAs and heart arrhythmia, among
other cardiac complications. miR-1, miR-133a-2, miR-133b, miR-
208a, and miR-208b were significantly downregulated in Chagas
disease patients in comparison to uninfected patients (heart
transplant donors). Moreover, in a comparison between two
cardiomyopathy groups (chronic Chagas disease patients and
dilated cardiomyopathy patients), miR-1, miR-133a-2, and miR-
208b expression was reduced in infected patients (Ferreira et al.,
2014). These microRNAs are highly enriched in the heart, where
they regulate heart development and myocyte differentiation
(Lagos-Quintana et al., 2002; Chen et al., 2006). In addition,
atypical expression of these microRNAs has been linked to
cardiovascular diseases (Carè et al., 2007; Ikeda et al., 2013).
Therefore, variations of host microRNAs in experimental models
of acute Chagas disease could shed light on the mechanism
that triggers heart clinical alterations, with possible relevance
for chronic Chagas disease patients with cardiomyopathy, as
the downregulation of miR-208 was detected in both patients
and mice infected by T. cruzi (Ferreira et al., 2014; Navarro
et al., 2015). It is noteworthy that cardiac damage releases
miR-208 and other factors into the bloodstream, and the levels
of these factors exhibit distinctive patterns that correlate with
different cardiovascular diseases, showing great potential for use
as biomarkers for cardiac illness (Gupta et al., 2010). However, no
data are available concerning circulating microRNAs in chronic
Chagas disease patients who develop cardiomyopathy.
In addition to heart manifestations, mice with acute T. cruzi
infection also present a severe thymic atrophy, primarily due to
the apoptosis of CD4+CD8+ double-positive immature T cells
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FIGURE 1 | MicroRNA modulation during parasitic infection: clues from
Gene Ontology (GO) enrichment analysis of microRNA in silico-predict
targets. (A) Mice with acute Trypanosoma cruzi infection modulate microRNA
expression in thymic epithelial cells, with some microRNAs upregulated (red)
and others undetectable (gray). The regulated microRNAs were used to
identify biological processes (depicted within the square) that were
over-represented among the list of microRNA target genes. (B) The
examination of mature microRNA expression patterns in human macrophages
revealed unique microRNA profiles in response to the Leishmania major and
L. donovani parasites. In addition, biological pathway enrichment was
performed for the dysregulated microRNAs to identify signaling pathways
(depicted within the square) that might be involved.
and also due to migratory abnormalities that release potential
autoreactive T cells to secondary lymphoid organs, which may
play a role in the chronic phase of the disease (Savino, 2006). The
development of increased T cell migration may be a consequence
of signals delivered by thymic epithelial cells (TECs) that enhance
the deposition of extracellular matrix proteins upon infection
(Cotta-de-Almeida et al., 2003; Pérez et al., 2012). These signals
might be under the control of microRNAs that are modulated
in TECs from infected mice before the induction of thymic
atrophy. Interestingly, microRNAs were primarily upregulated
(29 out of 85 microRNAs), even if the TECs that were sorted
from the thymus exhibited a cortical or medullary phenotype.
Furthermore, Gene Ontology (GO) enrichment analysis of
microRNA targets was used to identify biological processes that
were over-represented among the list of target genes (Figure 1A).
Indeed, the theoretical relationships of these microRNAs with
their putative RNA targets revealed transforming growth factor-β
(TGF-β) as a molecular node of infection, as the gene encoding
its receptor (the Tgfbr1 gene) appears in the middle of our
microRNA network, with 8 different microRNAs (let-7a, let-7g,
miR-101a, miR-148b, miR-193, miR-27a, miR-27b, and miR-30b)
regulating this gene (Linhares-Lacerda et al., 2015).
Taken together, these reports highlight the importance
of microRNA alterations in Chagas disease. Furthermore,
additional studies are needed to define microRNA biomarkers of
T. cruzi infection. In this context, it is reasonable to hypothesize
that miR-208 is a potential biomarker for T. cruzi infection
because this microRNA was downregulated in both the human
andmouse heart and undetectable in TECs from T. cruzi-infected
samples, revealing a possible common regulation pattern in
response to T. cruzi infection.
Macrophages Change their microRNA
Profiles in Response to Leishmania
Sophisticated strategies for surviving and establishing a
successful infection, such as antigen presentation inhibition,
were developed by Leishmania parasites, which cause cutaneous
or visceral diseases and are among the neglected diseases
(World Health Organization, 2010b). Leishmania is an obligate
intracellular pathogen in mammalian hosts and primarily
infects macrophages, where it avoids anti-parasitic responses
and subverts host innate immunity. The parasite modifies
both microRNAs and mRNAs from the host, leading to altered
expression of lipid metabolic genes, among other genes, resulting
in reduced cholesterol synthesis, the disruption of membrane
lipid rafts and the inhibition of antigen presentation to T cells
(Ghosh et al., 2013; Chakraborty et al., 2015).
Upon infection with L. major, human primary macrophages
change the microRNA-levels of 64 of 365 microRNAs, as
assessed via a quantitative PCR time course. These dysregulated
microRNAs virtually targeted several transcripts with critical
cellular functions, such as cellular movement, secretion,
communication, enzyme production, activity in the extracellular
space, signal transduction, and gene expression naturally
induced by an abiotic stimulus, which were all evaluated via a
GO enrichment analysis followed by a pathway analysis (Lemaire
et al., 2013). Additional examination of mature microRNA
expression patterns in L. major- and L. donovani-infected human
primary dendritic cells and macrophages using next-generation
sequencing revealed unique mature microRNA expression
profiles in response to both parasite species in different human
host cell types. Indeed, L. donovani-infected cells exhibited
higher expression of the identified microRNAs than L. major-
infected cells. The biological pathway enrichment was performed
again with predicted targets of the dysregulated microRNAs
and identified the mitogen-activated protein kinase (MAPK)
signaling pathway, among others (Figure 1B), regardless cell
type or the infecting Leishmania species (Geraci et al., 2015).
In general, those studies revealed the remarkable capacity
of Leishmania to modify microRNA expression in the host;
nevertheless, the biological significance of the dysregulated
microRNAs requires further investigation. For this purpose, the
use of microRNA mimics and inhibitors is an excellent tool. For
example, the transfection of the mmu-miR-210-5p inhibitor into
L. major-infected murine macrophages significantly decreased
the infection rates of these cells, suggesting a role of miR-210
in anti-parasitic activity (Frank et al., 2015). Moreover, the RNA
targets obtained via in silico prediction require experimental
evidence with further functional analysis to determine the role
of each microRNA/mRNA-target in the specific pathways in
which it participates. In the future, the knowledge gained from
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those investigations will assist in the discovery of new targets for
diagnostics or therapeutic approaches.
TRANS-KINGDOM TRANSFER OF
EXTRACELLULAR VESICLES
Cells exchange information with their environments, influencing
the behavior of other cells, and themselves. Cells can
communicate through a variety of chemical, mechanical,
and biological signals that trigger cell signaling and allow the
cells to process information from the outside to support survival.
Intercellular communication through biological signals involves
the transfer of many different molecules, such as hormones,
cytokines, and small RNAs, primarily via membrane vesicle
trafficking (Barteneva et al., 2013). Taking advantage of cellular
communication through the transfer of membrane-derived
extracellular vesicle (EV) cargo to host cells, parasites manipulate
host functions to establish a successful infection (Marcilla et al.,
2014). In this section, we review the trans-kingdom transfer of
EVs from T. cruzi and L. donovani to host cells.
Trypanosomatid Parasites Deliver Small
RNAs through Extracellular Vesicles to
Host Cells
EVs are key players in cell-to-cell communication. Like other
pathogens, T. cruzi releases proteins associated with vesicles
into the extracellular milieu to enable pathogen survival and
replication within the host (Marcilla et al., 2014). T. cruzi’s
protein vesicle content was defined in a proteomic study that
among other classes, identified a relatively high proportion of
RNA-binding proteins, suggesting a possible role in intercellular
communication and gene expression regulation (Bayer-Santos
et al., 2013). On the other hand, short transcriptome analysis
using unbiased and genome-wide deep sequencing indicated an
abundance of small RNAs derived from non-coding RNAs, of
which tRNA-derived small RNAs (tsRNAs) derived from the
3′end with a median length of 38 nt were the most frequently
detected type. Moreover, a comparison between certain tRNA
isoacceptors from which tsRNAs were derived revealed that
tsRNAs are differentially expressed and may be actively produced
rather than being random degradation products from tRNA
turnover (Franzén et al., 2011). Quite strikingly, T. cruzi lacks
functional RNAi machinery but does express a unique open
reading frame for an AGO/PIWI protein with the conserved
domain architecture of a canonical AGO in all stages of its life
cycle (Garcia-Silva et al., 2010b). Interestingly, tsRNA colocalizes
with this distinctive trypanosomatid AGO protein (TcPIWI-tryp)
in EVs that are transferred to surrounding parasites and to
susceptible mammalian host cells, where the protein changes
gene expression profiles (Garcia-Silva et al., 2010a, 2014a,b;
Figure 2).
Recently, evidences demonstrated that Leishmania parasites
release exosomes containing RNA sequences and that this
exosomos and their cargo can be internalized by host cells.
This is true for two different species of Leishmania, namely
L. donovani and L. braziliensis, suggesting that the packing of
FIGURE 2 | Transfer of parasitic extracellular vesicle cargo to host
cells. In this figure, we used a generic host cell to exemplify three different
molecules delivered by parasitic extracellular vesicles. In the upper left part of
the diagram, Trypanosoma cruzi releases EVs containing TS (trans-sialidase,
blue circles) that can trigger gene modulation through the MAPK signaling
pathway, which may be regulated by microRNAs. In the upper right part of
the diagram, Leishmania donovani releases GP63 vesicles (orange circles) that
cleave DICER (red), impairing microRNA maturation. Finally, in the bottom
part of the diagram, EVs containing tsRNA (tRNA-derived small RNAs, in
green) from Leishmania and from stressed Trypanosoma cruzi parasites
modulate gene expression and might form RNP complexes (green).
specific RNA sequences into exosomes may be a conserved
phenomenon in Leishmania (Lambertz et al., 2015). Like T. cruzi
the authors found a richness of tRNA fragments originating from
a small subset of tRNA isoacceptors, the tsRNAs, in both species,
moreover in L. braziliensis which is RNAi-competent organism,
they also found sequences derived from siRNA-coding regions in
both sense and anti-sense suggesting that they appear as double-
stranded RNAs in exosomes (Lambertz et al., 2015) (Figure 2).
Although these finds, the in vivo biological effect of EVs carrying
tsRNAs remains obscure, and more studies are required to assess
the molecular mechanisms associated with these non-coding
RNAs.
T. cruzi also releases EVs containing members of the trans-
sialidase glycoprotein superfamily. One member of this family
led to the aggravation of experimental Chagas disease, with
a severe inflammatory reaction of the heart and an increased
number of amastigote nests in animals that received these
EVs prior to T. cruzi infection (Trocoli Torrecilhas et al.,
2009). The T. cruzi trans-sialidase transfers host sialic acid to
parasite surface glycoconjugates, a process that supports host–cell
recognition, infectivity, and parasite survival. Indeed, this trans-
sialidase activity can remodel parasite glycomolecules, altering
host immune responses against the parasite and playing a role
as a virulence factor (Freire-de-Lima et al., 2012).
The presence of the trans-sialidase was confirmed in the
peripheral blood of chronic Chagas disease patients, where
the antibody titre against the trans-sialidase increased with
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the frequency of peripheral double-positive immature T cells,
potentially contributing to the clinical manifestations observed in
the chronic phase of the disease. On the other hand, the thymus
of T. cruzi-infected mice presents trans-sialidase depots near
the parasite nests, which play a role in thymic atrophy and the
premature release of double-positive CD4+CD8+ immature T
cells. In contrast, intrathymic trans-sialidase injection increased
the splenic double-positive immature T cell population and
activated the MAPK/JNK signaling pathway in immature T
cells (Nardy et al., 2013). Despite great advances toward
understanding the effects of theT. cruzi trans-sialidase (Alves and
Colli, 2010), the components involved in this signaling process
remain amystery. This process appears to be cell type-dependent,
with MAPK/ERK-1/2 induction in naive splenic CD4 T cells
(Todeschini et al., 2015), MAPK/JNK induction in immature
T cells (Freire-de-Lima et al., 2012) and NF–kB induction in
endothelial cells (Dias et al., 2008), but no microRNAs have been
described to date. We suggest miR-199a as a good candidate
for future studies of the T. cruzi trans-sialidase pathway. miR-
199a regulates the PI3K/Akt and ERK/MAPK signaling pathways
(Santhakumar et al., 2010) and targets a sialyltransferase (ST6
β-galactosamide α-2,6-sialyltransferase 1, ST6GAL1) (Minami
et al., 2013). In addition, miR-199a is upregulated during
human hypertrophy-related heart failure (van Rooij et al.,
2006); however, we do not know how the expression pattern
of miR-199a changes in the hearts of Chagas disease patients
(Figure 2).
Taken together, the EVs from T. cruzi could be an
additional strategy for modulating host cells via pathogen-
to-host communication through the delivery of tsRNAs and
virulence factors. However, the involvement of small RNAs is a
recent discovery, and more studies are needed to elucidate this
issue.
Exosome Cargo Impairs microRNA
Maturation during Leishmania donovani
Infection
During intercellular signaling and communication, EVs are
used as a mechanism to actively regulate protein release
from the cell. In Leishmania, changes in parasite culture
temperature (26/37◦C) lead to protein-specific enrichment
in vesicles, affecting the cargo of the released exosomes.
This exosome-based protein secretion mechanism delivers
cargo to macrophages and triggers biological effects, such
as the induction of interleukin-8 secretion (Silverman et al.,
2010). Thus, EVs serve as an excellent pathogen-to-host
communication process that could deliver effector molecules,
such as proteins, and may also release RNAs into the host
cytosol.
In this context, the delivery of the Leishmania surface
protein metalloprotease GP63, which is a membrane-bound
glycosylphosphatidylinositol (GPI)-anchored glycoprotein and a
known virulence factor (Brittingham et al., 1995), participates in
the parasite’s strategy to evade immune surveillance. L. donovani
extracts membrane cholesterol from macrophages, preventing
T cell stimulation and causing hypocholesterolaemia that leads
to protection against this infection, with an inverse correlation
between serum cholesterol levels and parasite load in infected
mice. In fact, the delivery of exosomes containing GP63 produced
by Kupffer cell-resident parasites to hepatocytes impairs miR-
122 activity by cleaving DICER1, which is a primary target of
GP63 (Ghosh et al., 2012, 2013; Figure 2). DICER1 processes
pre-microRNAs into mature microRNAs and transfers those
microRNAs to AGO, forming the RNP complex. In the presence
of GP63, hepatocytes accumulated pre-miR-122 and failed
to form the RNP-miR-122 complex, possibly leading to the
downregulation of cholesterol synthesis because miR-122 is
responsible for lipid metabolism and liver homeostasis (Girard
et al., 2008; Ghosh et al., 2013). Interestingly, the restoration
of Dicer1 expression in parasite-infected livers increased miR-
122 expression and restored serum cholesterol levels, with
a drastic reduction in liver parasite load. Therefore, this
process is a sophisticated example of how parasites evolved
strategies to combat regulatory RNA functions in host cells,
leading to an important metabolic change that promotes
pathogenesis.
CONCLUDING REMARKS
Although few publications are available on this topic, current
knowledge emphasizes the alteration of microRNA profiles
during infection and EV cargo delivery during host interactions
with the parasites T. cruzi, L. major, and L. donovani, which lack
functional RNAi machinery. In this mini review, we highlighted
some interesting findings in these fields and raised questions
for further investigation, such as the status of miR-208 as a
potential biomarker for T. cruzi infection, the presence of tsRNA
in Leishmania EVs and the involvement of microRNAs in trans-
sialidase triggered pathways during T. cruzi infection.
The main open question is to determine the role of
each microRNA/mRNA-target in specific pathways through
functional analysis and to investigate the importance of these
factors in pathogenesis. The knowledge acquired from these
futures studies will be useful for aiding the discovery of new
targets for diagnosis or therapeutic approaches.
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